|
2025
|
Invention
|
Variants of epstein-barr virus glycoprotein b, nucleic acids encoding the same, and uses thereof.... |
|
|
G/S
|
Pharmaceutical preparations for the treatment of immune system related diseases and disorders; An... |
|
|
G/S
|
Pharmaceutical products for the treatment and prevention of immune system related diseases and di... |
|
|
G/S
|
Pharmaceutical products, vaccines. |
|
|
G/S
|
Pharmaceutical products, vaccines |
|
|
G/S
|
Pharmaceutical products, vaccines |
|
|
G/S
|
Pharmaceuticals; Vaccines. |
|
|
G/S
|
Pharmaceutical products, vaccines. |
|
|
G/S
|
Pharmaceutical products; vaccines. |
|
|
G/S
|
Vaccines for human use |
|
|
G/S
|
Vaccines for human use. |
|
|
G/S
|
Pharmaceutical preparations for the treatment of immune system related diseases and disorders; an... |
|
|
G/S
|
Pharmaceutical preparations for the treatment of immune system related diseases and disorders, na... |
|
2024
|
Invention
|
Compositions for use in treatment of chlamydia |
|
2023
|
Invention
|
Primers and probes for detecting mycobacteria. The present invention is directed to a set of prim... |
|
|
Invention
|
Modified vero cells and methods of using the same for virus production. Disclosed herein is an en... |
|
2021
|
Invention
|
Liposomes containing tlr4 agonist, preparation and uses thereof. The present invention relates to... |
|
|
Invention
|
Improved diagnostic tests. The present invention provides an immunodiagnostic test device for the... |
|
|
Invention
|
Internal cardboard support for receiving pharmaceutical products, packaging and method for packag... |
|
|
Invention
|
Lipidic compounds comprising at least one terminal radical of formula -nh-cx-a or -nh-cx-nh-a, co... |
|
|
Invention
|
Cleavable lipidic compounds, compositions containing thereof, and uses thereof. The disclosure re... |
|
|
Invention
|
Cleavable lipidic compounds, compositions containing thereof, and uses thereof. 105555 lipophilic... |
|
2020
|
Invention
|
Method for determining at a current time point a preservation state of one product and computer s... |
|
2019
|
Invention
|
Ready-to-sell packaging unit containing at least one pharmaceutical product, set including a plur... |
|
|
Invention
|
Live-attenuated yellow fever virus strain adapted to grow on vero cells and vaccine composition c... |
|
2018
|
Invention
|
Flavivirus vaccine. The present invention is directed to an artificial nucleic acid and to a poly... |
|
|
Invention
|
Compositions for booster vaccination against dengu. The present invention is directed to a method... |
|
|
Invention
|
Human cytomegalovirus immunogenic composition. The invention relates to an immunogenic compositio... |
|
2017
|
Invention
|
Live attenuated chimeric zika virus and its use as an immunogenic composition. The present invent... |
|
|
Invention
|
Novel immunogenic formulations comprising linear or branched polyacrylic acid polymer adjuvants. ... |
|
|
Invention
|
Zika virus vaccine. The present invention is directed to an artificial nucleic acid and to polype... |
|
2016
|
Invention
|
Immunogenic compositions against s. aureus. The invention relates to a conjugate of a saccharide ... |
|
|
Invention
|
Concomitant dengue, diphtheria, tetanus, whooping cough (pertussis), polio, and haemophilus influ... |
|
|
Invention
|
Concomitant dengue and yellow fever vaccination. The present invention relates to a yellow fever ... |
|
|
Invention
|
Meningitidis vaccines comprising subtilinases. The present invention relates to novel polypeptide... |
|
2015
|
Invention
|
Multimerization of recombinant protein by fusion to a sequence from lamprey. The present inventio... |
|
|
Invention
|
Compositions comprising n. meningitidis proteins. The invention relates to immunogenic compositio... |
|
|
Invention
|
Neisseria meningitidis trypsin-like serine protease polypeptides and compositions thereof. The pr... |
|
|
Invention
|
Vaccine compositions against dengue virus diseases. The present invention relates to vaccine comp... |
|
|
Invention
|
Liquid feeding device for the generation of droplets. The present invention provides, inter alia,... |
|
|
Invention
|
Vaccine composition comprising ipv and cyclodextrins. The present invention is directed to an imm... |
|
2014
|
Invention
|
Induction of cross-reactive cellular response against rhinovirus antigens. The present inve... |
|
|
Invention
|
Induction of cross-reactive cellular response against rhinovirus antigens. The present invention ... |
|
2013
|
Invention
|
Methods for inducing antibodies. The present invention provides agents for use in methods of indu... |
|
|
Invention
|
Vaccination against japanese encephalitis, measles, mumps and rubella. The invention relates to a... |
|
|
Invention
|
Production of infectious influenza viruses. The invention relates to a method for producing influ... |
|
|
Invention
|
Vaccine compositions for prevention against dengue virus infection. The present invention relates... |
|
|
Invention
|
Vaccine compositions for use in a method of protecting a human subject against dengue disease. Th... |
